We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Gogo (NASDAQ:GOGO) Sinks Toward 52-Week Lows as Q2 Miss Overshadows Military Surge

● Gogo is trading near 52-week lows after a disappointing second-quarter report knocked shares down sharply in early August 2026.

Nitish Kishor | 17 August 2026

3D Systems (NYSE:DDD) Shares Rally to 52-Week High as Cost Cuts Narrow Losses

● 3D Systems shares rallied to a 52-week high, a significantReversalafter years of painfulRevenuedecline.

Nitish Kishor | 17 August 2026

Direct Digital Holdings (NASDAQ:DRCT) Fights for Its Listing as Ad-Tech Turnaround Lags

● The company's coreSell-Sidebusiness, built around the Colossus SSP platform, continues shrinking dramatically.

Nitish Kishor | 17 August 2026

Editas Medicine (NASDAQ:EDIT) Bets Its Future on a Single In Vivo Cholesterol-Editing Candidate

● Editas Medicine has spent the past 20 months rebuilding itself around a single new strategic direction.

Nitish Kishor | 17 August 2026

Eve Holding (NYSE:EVEX) Narrows Loss, Hits First Transition Flight as Shares Hover Near 52-Week Low

● The company achieved a milestone first transition flight for its Eve 100 eVTOL aircraft.

Nitish Kishor | 17 August 2026

CVRx (NASDAQ:CVRX) Shares Steady After Guidance Cut as Barostim Sales Collide With Execution Setbacks

● CVRx shares closed at $2.94 on August 13, 2026, up 7.69% on the day, rebounding after an earlier decline.

Nitish Kishor | 17 August 2026

AirSculpt (NASDAQ:AIRS) Shares Slide on Revenue Miss, Leans on GLP-1 Rebound Story

● AirSculpt Technologies reported second-quarterRevenuebelow the roughly $44.2 million analysts had modeled, coming in under $44.0 million a year earlier.

Nitish Kishor | 17 August 2026

Bolt Biotherapeutics (NASDAQ:BOLT) Fights the Clock as Cash Runs to Q1 2027, Pivotal Data Due Before It

● Bolt Biotherapeutics is a clinical-stage immuno-oncology company built around its Boltbody immune-stimulating antibody conjugate platform.

Nitish Kishor | 17 August 2026

America's Car-Mart (NASDAQ:CRMT) Fights for Survival as Subprime Losses Wipe Out 93% of Market Value

● America's Car-Mart closed near $3.09 on August 14, 2026, reflecting a dramatic decline from prior levels.

Nitish Kishor | 17 August 2026

Advanced Flower Capital (NASDAQ:AFCG) Jumps on NAV Growth as BDC Pivot Masks Credit Scars

● The company, once known as AFC Gamma, spun off itsCommercial Real Estatebook as Sunrise Realty Trust in 2024.

Nitish Kishor | 17 August 2026
Support

Hi! How can we help you today?

Loading…